{
  "id": "clinical#screening_cues_67a314ba",
  "content": "Specify if:\nIn a controlled environment: This additional specifier is used if\nthe individual is in an environment where access to phencycli-\ndines is restricted.\nCoding based on current severity: Note for ICD-10-CM codes: If a\nphencyclidine intoxication or another phencyclidine-induced mental dis-\norder is also present, do not use the codes below for phencyclidine use\ndisorder. Instead, the comorbid phencyclidine use disorder is indicated\nin the 4th character of the phencyclidine-induced disorder code (see the\ncoding note for phencyclidine intoxication or a specific phencyclidine-\ninduced mental disorder). For example, if there is comorbid phencycli-\ndine-induced psychotic disorder, only the phencyclidine-induced psy-\nchotic disorder code is given, with the 4th character indicating whether\nthe comorbid phencyclidine use disorder is mild, moderate, or severe:\nF16.159 for mild phencyclidine use disorder with phencyclidine-induced\npsychotic disorder or F16.259 for a moderate or severe phencyclidine\nuse disorder with phencyclidine-induced psychotic disorder.\nSpecify current severity:\n305.90 (F16.10) Mild: Presence of 2–3 symptoms\n304.60 (F16.20) Moderate: Presence of 4–5 symptoms\n304.60 (F16.20) Severe: Presence of 6 or more symptoms\nOther Hallucinogen Use Disorder\nA. A problematic pattern of hallucinogen (other than phencyclidine)\nuse leading to clinically significant impairment or distress, as",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "study",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues Specify if:\nIn a controlled environment: This additional specifier is used if\nthe individual is in an environment where access to phencycli-\ndines is restricted.\nCoding based on current severity: Note for ICD-10-CM codes: If a\nphencyclidine intoxication or another phencyclidine-induced mental dis-\norder is also present, do not use the codes below for phencyclidine use\ndisorder. Instead, the comorbid phencyclidine use disorder is indicated\nin the 4th character of the phencyclidine-induced disorder code (see the\ncoding note for phencyclidine intoxication or a specific phencyclidine-\ninduced mental disorder). For example, if there is comorbid phencycli-\ndine-induced psychotic disorder, only the phencyclidine-induced psy-\nchotic disorder code is given, with the 4th character indicating whether\nthe comorbid phencyclidine use disorder is mild, moderate, or severe:\nF16.159 for mild phencyclidine use disorder with phencyclidine-induced\npsychotic disorder or F16.259 for a moderate or severe phencyclidine\nuse disorder with phencyclidine-induced psychotic disorder.\nSpecify current severity:\n305.90 (F16.10) Mild: Presence of 2–3 symptoms\n304.60 (F16.20) Moderate: Presence of 4–5 symptoms\n304.60 (F16.20) Severe: Presence of 6 or more symptoms\nOther Hallucinogen Use Disorder\nA. A problematic pattern of hallucinogen (other than phencyclidine)\nuse leading to clinically significant impairment or distress, as Specify if:\nin a controlled environment: this additional specifier is used if\nthe individual is in an environment where access to phencycli-\ndines is restricted. coding based on current severity: note for icd-10-cm codes..."
}